Human MxA Protein Inhibits the Replication of Crimean-Congo Hemorrhagic Fever Virus
Open Access
- 15 April 2004
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 78 (8) , 4323-4329
- https://doi.org/10.1128/jvi.78.8.4323-4329.2004
Abstract
Crimean-Congo hemorrhagic fever virus (CCHFV) belongs to the genus Nairovirus within the family Bunyaviridae and is the causative agent of severe hemorrhagic fever. Despite increasing knowledge about hemorrhagic fever viruses, the factors determining their pathogenicity are still poorly understood. The interferon-induced MxA protein has been shown to have an inhibitory effect on several members of the Bunyaviridae famil y , but the effect of MxA against CCHFV has not previously been studied. Here, we report that human MxA has antiviral activity against CCHFV. The yield of progeny virus in cells constitutively expressing MxA was reduced up to 1,000-fold compared with control cells, and accumulation of viral genomes was blocked. Confocal microscopy revealed that MxA colocalizes with the nucleocapsid protein (NP) of CCHFV in the perinuclear regions of infected cells. Furthermore, we found that MxA interacted with NP by using a coimmunoprecipitation assay. We also found that an amino acid substitution (E645R) within the C-terminal domain of MxA resulted in a loss of MxA antiviral activity and, concomitantly, in the capacity to interact with CCHFV NP. These results suggest that MxA, by interacting with a component of the nucleocapsid, prevents replication of CCHFV viral RNA and thereby inhibits the production of new infectious virus particles.Keywords
This publication has 48 references indexed in Scilit:
- Role of actin filaments in targeting of Crimean Congo hemorrhagic fever virus nucleocapsid protein to perinuclear regions of mammalian cellsJournal of Medical Virology, 2003
- The Efficacy of Oral Ribavirin in the Treatment of Crimean-Congo Hemorrhagic Fever in IranClinical Infectious Diseases, 2003
- Genetic variability of Crimean-Congo haemorrhagic fever virus in Russia and Central AsiaJournal of General Virology, 2003
- Viral Evasion of the Interferon System: Old Viruses, New TricksJournal of Interferon & Cytokine Research, 2003
- Genetic Analysis of Crimean-Congo Hemorrhagic Fever Virus in RussiaJournal of Clinical Microbiology, 2003
- Characterization of the Glycoproteins of Crimean-Congo Hemorrhagic Fever VirusJournal of Virology, 2002
- Expression of Human MxA Protein in Mosquito Cells Interferes with LaCrosse Virus ReplicationJournal of Virology, 2001
- Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activatorAntiviral Research, 1986
- Identification of a Major Non-structural Protein in the Nuclei of Rift Valley Fever Virus-infected CellsJournal of General Virology, 1982
- CONGO/CRIMEAN HÆMORRHAGIC FEVER IN DUBAI: An Outbreak at the Rashid HospitalPublished by Elsevier ,1980